Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE MICHAEL SHAHIN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1508278912
CMS profile
1379519
Location
BILOXI, MS

General Payments · PY2019–2024

$2,229.46

  • Reported across 72 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$362.68

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $362.68 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $508.85 5
PY2020 $235.41 11
PY2021 $92.48 5
PY2022 $265.64 11
PY2023 $764.40 23
PY2024 $362.68 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $20.64 04/24/2024 Food and Beverage Undisputed 01/23/2026 1139352743 CMS
Astellas Pharma US Inc $28.95 07/18/2024 Food and Beverage Undisputed 01/23/2026 1139270418 CMS
AstraZeneca Pharmaceuticals LP $16.28 10/10/2024 Food and Beverage Undisputed 01/23/2026 1104356533 CMS
AstraZeneca Pharmaceuticals LP $17.28 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104567030 CMS
AstraZeneca Pharmaceuticals LP $15.59 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105308046 CMS
Aveo Pharmaceuticals, Inc. $15.88 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143477665 CMS
Celgene Corporation $17.34 11/14/2024 Food and Beverage Undisputed 01/23/2026 1101176052 CMS
Daiichi Sankyo Inc. $20.15 04/25/2024 Food and Beverage Undisputed 01/23/2026 1089481215 CMS
Gilead Sciences, Inc. $15.45 04/10/2024 Food and Beverage Undisputed 01/23/2026 1133798944 CMS
Gilead Sciences, Inc. $28.57 05/21/2024 Food and Beverage Undisputed 01/23/2026 1133798946 CMS
Incyte Corporation $25.41 10/09/2024 Food and Beverage Undisputed 01/23/2026 1141184030 CMS
Merck Sharp & Dohme LLC $32.06 01/17/2024 Food and Beverage Undisputed 01/23/2026 1141654427 CMS
Merck Sharp & Dohme LLC $25.10 03/11/2024 Food and Beverage Undisputed 01/23/2026 1141654429 CMS
Merck Sharp & Dohme LLC $22.67 04/11/2024 Food and Beverage Undisputed 01/23/2026 1141654425 CMS
PROGENICS PHARMACEUTICALS, INC. $27.37 08/15/2024 Food and Beverage Undisputed 01/23/2026 1128507358 CMS
Regeneron Healthcare Solutions, Inc. $17.70 07/15/2024 Food and Beverage Undisputed 01/23/2026 1114168449 CMS
SOBI, INC $16.24 05/09/2024 Food and Beverage Undisputed 01/23/2026 1141421309 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.